webinar register page

Webinar banner
Closing the PLM Loop to Overcome a Disrupted Life-Sciences Reality - An Axendia "Straight from the Source" Webinar


Jul 15, 2020 09:57 AM

Webinar logo
* Required information


Chuck Serrin
VP Industry Marketing for Med Tech and Life Sciences @Propel
Chuck Serrin is the Vice President of Industry Marketing for Med Tech and Life Sciences at Propel. Serrin’s previous experience includes 10 years at Stryker Corporation, where he was a Business Partner, Program Manager and Solution Architect responsible for implementing and supporting global PLM, QMS and digital transformation projects. Prior to Stryker, he held senior level positions with enterprise software companies such as Agile Software, Oracle and PTC. Serrin brings deep domain expertise on the development, compliance and commercialization of medical device products, along with providing high-quality support in launching new products.
Kevin Chien
Vice President, Medtech Strategy @Salesforce
Kevin Chien is a global digital health and medtech commercial leader with 18 years of experience in bringing new technologies to market and building category leading brands. Kevin currently serves as Vice President, Medtech Strategy at Salesforce where he works with large medical technology companies on driving digital transformation initiatives and defining Salesforce's life science strategy. Prior to Salesforce, Kevin was Vice President, Global Market Development at Heartflow, where he led various programs to drive growth through new technologies, indications, and geographies and executing on go-to-market plans. Kevin also held various global marketing and sales operations leadership roles at Boston Scientific and Stryker, including leading the global commercialization of the first billion dollar brand in stroke interventions. He holds a BA, Magna Cum Laude in Economics and Pre-Medical Sciences from Harvard University and an MBA from the Stanford Graduate School of Business.
Daniel R. Matlis
President @Axendia Inc.
Dan has almost three decades of industry experience spanning the Health-Science value chain. He has been an active member in FDA’s Case for Quality Initiative since 2014 and has presented Axendia’s research findings to industry executives and the FDA officials. He is a frequent lecturer at Industry events and has published numerous research reports and articles on key issues facing the Life-Sciences and Healthcare industries.